Cargando…
Asthma exacerbations: Origin, effect, and prevention
Asthma is the most common chronic respiratory disease, affecting up to 10% of adults and 30% of children in the Western world. Despite advances in asthma management, acute exacerbations continue to occur and impose considerable morbidity on patients and constitute a major burden on health care resou...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172902/ https://www.ncbi.nlm.nih.gov/pubmed/22133317 http://dx.doi.org/10.1016/j.jaci.2011.10.024 |
_version_ | 1783524348568535040 |
---|---|
author | Jackson, David J. Sykes, Annemarie Mallia, Patrick Johnston, Sebastian L. |
author_facet | Jackson, David J. Sykes, Annemarie Mallia, Patrick Johnston, Sebastian L. |
author_sort | Jackson, David J. |
collection | PubMed |
description | Asthma is the most common chronic respiratory disease, affecting up to 10% of adults and 30% of children in the Western world. Despite advances in asthma management, acute exacerbations continue to occur and impose considerable morbidity on patients and constitute a major burden on health care resources. Respiratory tract viruses have emerged as the most frequent triggers for exacerbations in both children and adults; however, the mechanisms underlying these remain poorly understood. More recently, it has become increasingly clear that interactions might exist between viruses and other triggers, increasing the likelihood of an exacerbation. In this article we begin with an overview of the health, economic, and social burden that exacerbations of asthma carry with them. This is followed by a review of the pathogenesis of asthma exacerbations, highlighting the various triggers responsible and multiple interactions that exist between them. The final section first addresses what preventative measures are currently available for asthma exacerbations and subsequently examines which of the new treatments in development might lessen the burden of exacerbations in the future. |
format | Online Article Text |
id | pubmed-7172902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71729022020-04-22 Asthma exacerbations: Origin, effect, and prevention Jackson, David J. Sykes, Annemarie Mallia, Patrick Johnston, Sebastian L. J Allergy Clin Immunol Reviews and Feature Article Asthma is the most common chronic respiratory disease, affecting up to 10% of adults and 30% of children in the Western world. Despite advances in asthma management, acute exacerbations continue to occur and impose considerable morbidity on patients and constitute a major burden on health care resources. Respiratory tract viruses have emerged as the most frequent triggers for exacerbations in both children and adults; however, the mechanisms underlying these remain poorly understood. More recently, it has become increasingly clear that interactions might exist between viruses and other triggers, increasing the likelihood of an exacerbation. In this article we begin with an overview of the health, economic, and social burden that exacerbations of asthma carry with them. This is followed by a review of the pathogenesis of asthma exacerbations, highlighting the various triggers responsible and multiple interactions that exist between them. The final section first addresses what preventative measures are currently available for asthma exacerbations and subsequently examines which of the new treatments in development might lessen the burden of exacerbations in the future. American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. 2011-12 2011-11-28 /pmc/articles/PMC7172902/ /pubmed/22133317 http://dx.doi.org/10.1016/j.jaci.2011.10.024 Text en Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Reviews and Feature Article Jackson, David J. Sykes, Annemarie Mallia, Patrick Johnston, Sebastian L. Asthma exacerbations: Origin, effect, and prevention |
title | Asthma exacerbations: Origin, effect, and prevention |
title_full | Asthma exacerbations: Origin, effect, and prevention |
title_fullStr | Asthma exacerbations: Origin, effect, and prevention |
title_full_unstemmed | Asthma exacerbations: Origin, effect, and prevention |
title_short | Asthma exacerbations: Origin, effect, and prevention |
title_sort | asthma exacerbations: origin, effect, and prevention |
topic | Reviews and Feature Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172902/ https://www.ncbi.nlm.nih.gov/pubmed/22133317 http://dx.doi.org/10.1016/j.jaci.2011.10.024 |
work_keys_str_mv | AT jacksondavidj asthmaexacerbationsorigineffectandprevention AT sykesannemarie asthmaexacerbationsorigineffectandprevention AT malliapatrick asthmaexacerbationsorigineffectandprevention AT johnstonsebastianl asthmaexacerbationsorigineffectandprevention |